Star Combo Pharma Ltd (S66) — Capital Reinvestment Ratio
Star Combo Pharma Ltd (S66) has a Capital Reinvestment Ratio of 0.51x as of December 2025, meaning it reinvests 1% of its operating cash flow (AU$575.23K) in capital expenditures (AU$295.53K). See Star Combo Pharma Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Star Combo Pharma Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Star Combo Pharma Ltd's Capital Reinvestment Ratio across 6 annual periods. Check S66 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Star Combo Pharma Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Star Combo Pharma Ltd from 2016 to 2025. For live market cap and broader valuation context, see Star Combo Pharma Ltd (S66) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | AU$11.94 Million | AU$393.72K | ▼ -97.7% |
| 2023 | 1.45x | AU$1.88 Million | AU$2.73 Million | ▼ -98.3% |
| 2022 | 83.74x | AU$87.11K | AU$7.29 Million | ▲ +282.5% |
| 2021 | 21.89x | AU$331.53K | AU$7.26 Million | ▲ +7714.6% |
| 2017 | 0.28x | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.30 Million | AU$1.15 Million | — |